| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |